News
Warfarin Discontinuation Linked to Increased Risk of Death, Adverse Events in Very Elderly
Physician-perceived frailty and low life expectancy are the main reasons for warfarin discontinuation in elderly patients
Your search for Warfarin returned 34 results
News
Benefits of Warfarin After Dementia Diagnosis Explored
For veterans receiving warfarin for nonvalvular atrial fibrillation, continuing warfarin after a diagnosis of dementia is associated with a protective effect in prevention of stroke and mortality, according to a study published online December 30 in the Journal of the American Geriatrics Society.
News
Drug Interaction Possible When HCV Regimens Added to Warfarin
A retrospective cohort study in the Annals of Pharmacotherapy found a clinically significant decrease in warfarin dose-response with concurrent hepatitis C treatments, especially with ombitasvir/paritaprevir/ritonavir and dasabuvir (OBV-PTV/r-DSV).
News
Same-day genetic testing service available for safer warfarin dosing
Machaon Diagnostics has launched a same-day genetic testing service for patients that have been prescribed warfarin (Coumadin, from Bristol-Myers Squibb).
News
Impact of Oral Anticoagulants on Renal Outcomes Compared
Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes
Drugs in the Pipeline
Phase 3 Study Update of 4-Factor Prothrombin Complex Concentrate for Hemostasis
CSL Behring announced results of a Phase 3b study that showed that a balanced, human 4-factor prothrombin complex concentrate (PCC) is as effective as the current standard of treatment in stopping bleeding in patients receiving vitamin K antagonist therapy (eg, warfarin).
Drugs in the Pipeline
Phase 3 Study of Eliquis for Stroke Prevention
Bristol-Myers Squib and Pfizer announced results from their Phase 3 ARISTOTLE study of Eliquis (apixaban tablet) in patients with atrial fibrillation (AF) and at least one additional risk factor for stroke.
News
Long-Term Warfarin in AFib Patients May Up Dementia Risk
Patients with atrial fibrillation taking long-term warfarin had higher rates of dementia than non-atrial fibrillation patients, a study presented at the Heart Rhythm Society's 37th Annual Scientific Sessions has found.
Drugs in the Pipeline
Phase 3 study of rivaroxaban for the treatment of stroke associated with atrial fibrillation (AF)
Johnson & Johnson Pharmaceutical Research & Development announced results from its Phase 3 study of rivaroxaban in non-valvular atrial fibrillation (AF) patients to reduce the risk of stroke and non-CNS systemic embolism.
News
Rivaroxaban Tied to Lower Brain Bleed Risk in A-Fib
A once daily oral dose of rivaroxaban (Xarelto) significantly lowers the risk of intracranial hemorrhage (ICH) in patients with atrial fibrillation (AF) at moderate to high risk of stroke.
